Haemorrhagic fever with renal syndrome bivalent purified vaccine, Vero cell (Jilin Yatai Bio-Pharmaceutical)

双价肾综合征出血热纯化疫苗(Vero)（吉林亚泰）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHaemorrhagic fever with renal syndrome bivalent purified vaccine, Vero cell (Jilin Yatai Bio-Pharmaceutical)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fevers, Viral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesJilin Yatai (Group) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJilin Yatai (Group) Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fevers, Viral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A